List of Excipients in API xanomeline and trospium chloride
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing xanomeline and trospium chloride
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| ER Squibb & Sons LLC | COBENFY | xanomeline and trospium chloride | 0003-0050 | ASCORBIC ACID | 2029-09-26 |
| ER Squibb & Sons LLC | COBENFY | xanomeline and trospium chloride | 0003-0050 | CELLULOSE, MICROCRYSTALLINE | 2029-09-26 |
| ER Squibb & Sons LLC | COBENFY | xanomeline and trospium chloride | 0003-0050 | FERRIC OXIDE RED | 2029-09-26 |
| ER Squibb & Sons LLC | COBENFY | xanomeline and trospium chloride | 0003-0050 | FERRIC OXIDE YELLOW | 2029-09-26 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for xanomeline and trospium chloride
Excipient focus: ASCORBIC ACID
xanomeline and trospium chloride drug variants containing ASCORBIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| ER Squibb & Sons LLC | xanomeline and trospium chloride | 0003-0050 |
| >Company | >Ingredient | >NDC |
xanomeline and trospium chloride drug variants not containing ASCORBIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
xanomeline and trospium chloride drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| ER Squibb & Sons LLC | xanomeline and trospium chloride | 0003-0050 |
| >Company | >Ingredient | >NDC |
xanomeline and trospium chloride drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
xanomeline and trospium chloride drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| ER Squibb & Sons LLC | xanomeline and trospium chloride | 0003-0050 |
| >Company | >Ingredient | >NDC |
xanomeline and trospium chloride drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
xanomeline and trospium chloride drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| ER Squibb & Sons LLC | xanomeline and trospium chloride | 0003-0050 |
| >Company | >Ingredient | >NDC |
xanomeline and trospium chloride drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
xanomeline and trospium chloride drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| ER Squibb & Sons LLC | xanomeline and trospium chloride | 0003-0050 |
| >Company | >Ingredient | >NDC |
xanomeline and trospium chloride drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
xanomeline and trospium chloride drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| ER Squibb & Sons LLC | xanomeline and trospium chloride | 0003-0050 |
| >Company | >Ingredient | >NDC |
xanomeline and trospium chloride drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
xanomeline and trospium chloride drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| ER Squibb & Sons LLC | xanomeline and trospium chloride | 0003-0050 |
| >Company | >Ingredient | >NDC |
xanomeline and trospium chloride drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
xanomeline and trospium chloride drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| ER Squibb & Sons LLC | xanomeline and trospium chloride | 0003-0050 |
| >Company | >Ingredient | >NDC |
xanomeline and trospium chloride drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch